A Study of PRT543 in Participants With Advanced Solid Tumors and Hematologic Malignancies

Clinical trial NCT03886831 · COMPLETED

Trial details

NCT number: NCT03886831
Sponsor: Prelude Therapeutics
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed/Refractory Advanced Solid Tumors Relapsed/Refractory Diffuse Large B-cell Lymphoma Relapsed/Refractory Myelodysplasia Relapsed/Refractory Myelofibrosis Adenoid Cystic Carcinoma Relapsed/Refractory Mantle Cell Lymphoma Relapsed/Refractory Acute Myeloid Leukemia Refractory Chronic Myelomonocytic Leukemia

Start date: 2019-02-11
Primary completion: 2022-11-16
Enrollment: 232

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.